AYUMI Pharmaceutical - Ownership and Business Overview

Life ScienceCompany

AYUMI Pharmaceutical Ownership

Who owns AYUMI Pharmaceutical?

AYUMI Pharmaceutical is owned by The Blackstone Group. It was acquired on March 15, 2019.

Is AYUMI Pharmaceutical PE-backed?

Yes. AYUMI Pharmaceutical is owned by private equity investor The Blackstone Group.

Was AYUMI Pharmaceutical formerly PE-backed?

Yes. AYUMI Pharmaceutical was formerly owned by 1 private investor.

AYUMI Pharmaceutical Business Overview

Where is AYUMI Pharmaceutical headquartered?

AYUMI Pharmaceutical is headquartered in Tokyo, Japan.

What sector is AYUMI Pharmaceutical in?

AYUMI Pharmaceutical is a life science company.

When was AYUMI Pharmaceutical founded?

AYUMI Pharmaceutical was founded in 2015.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 245 acquisitions of life science companies in 2019, including 40 acquisitions by private equity firms, and 205 by strategics.

AYUMI Pharmaceutical

AYUMI Pharmaceutical Corp.

Kabukiza Tower 19F, 4-12-15 Ginza,
Tokyo, 104-0061
Japan,
+81-3-6264-3540
www.ayumi-pharma.com

AYUMI Pharmaceutical is a manufacturer and sale of medicines used in the treatment of rheumatism and other pharmaceuticals. AYUMI Pharmaceutical was founded in 2015 and is based in Tokyo, Japan.


 Subscribe to unlock this and 202,187
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AYUMI Pharmaceutical

Life Science Companies , Japan Companies